Naunyn-Schmiedeberg’s Archives of Pharmacology under new editorship: change and continuity

Seifert, Roland

doi:10.1007/s00210-016-1261-3

Cited by 2 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, Naunyn-Schmiedeberg's Archives of Pharmacology is a journal which not only publishes positive results but encourages authors to publish solid "negative" results (Seifert 2016). Therefore, authors can publish "negative" data on controversial issues in the journal which are then discussed in social media.…”

Section: Editorial Analysismentioning

confidence: 99%

“…What will be the future development of the journal? Naunyn-Schmiedeberg's Archives of Pharmacology is known for its fair and constructive review process (Starke 1998;Seifert 2016). The journal has a "science first" policy, allowing flexible publication formats and no incentives to artificially increase its impact factor.…”

Section: Conclusion and Future Perspectivesmentioning

confidence: 99%

See 1 more Smart Citation

Bibliometric development of Naunyn–Schmiedeberg’s Archives of Pharmacology

Dats

Haugwitz

Seifert

2022

Naunyn-Schmiedeberg's Arch Pharmacol

View full text Add to dashboard Cite

Motivated by the 150-year anniversary of the Naunyn–Schmiedeberg’s Archives of Pharmacology in 2023, we studied the bibliometric development of the journal. We evaluated data from Editorial Reports, Clarivate, and Springer Nature databases. Several parameters representing the journal’s performance, such as the impact factor and social impact, were analyzed over the years. We analyzed the journal’s meta-data and wrote an algorithm to retrieve cities and countries of origin. We could see a decrease in publications from Germany and an increase in papers from Brazil, China, Egypt, and Iran during the last years. The decrease in publications from Germany is probably a zeitgeist effect because this country places a strong emphasis on high-impact factor papers for academic promotion and winning grants. Germany was the country with the most publications throughout the 100 most-cited articles. Most of these articles were published between 1970 and 1990, when neurotransmitters were the most published topic. Klaus Starke (Freiburg) and Manfred Göthert (Bonn) were prominent drivers of this field. The most common topics nowadays are “Drugs for the Treatment of Malignant Tumor Diseases” and “Immunopharmacology.” The internationality of the journal substantially increased after introduction of English as mandatory language in the 1970s. The journal also experienced substantial COVID-19 pandemic-related effects. This paper is not only of relevance for the field of pharmacology but for science in general in the sense that Naunyn–Schmiedeberg’s Archives of Pharmacology is a case study for profound changes in a traditional scientific journal, requiring permanent adjustment by editors, referees, publisher, authors, and readers alike. The development of the journal has been strongly influenced by historic and political developments, cultural attitudes (zeitgeist), language changes, global changes in research topics, and eminent individuals who published many papers in Naunyn–Schmiedeberg’s Archives of Pharmacology.

show abstract

Section: Editorial Analysismentioning

confidence: 99%

Section: Conclusion and Future Perspectivesmentioning

confidence: 99%

Bibliometric development of Naunyn–Schmiedeberg’s Archives of Pharmacology

Dats

Haugwitz

Seifert

2022

Naunyn-Schmiedeberg's Arch Pharmacol

View full text Add to dashboard Cite

show abstract

“…The Editors of Naunyn–Schmiedeberg’s Archives of Pharmacology (initially under the leadership of Martin C Michel and later Roland Seifert) continued to promote the journal by offering fair and constructive peer review (Seifert 2016 ). In fact, international publications have very well compensated for the massive loss of publications from Germany during the past 25 years (Dats et al 2023 ).…”

Section: The Challengesmentioning

confidence: 99%

Reflections on the 150th anniversary of Naunyn–Schmiedeberg’s Archives of Pharmacology: past, challenges, and future

Hattori

Seifert

2022

Naunyn-Schmiedeberg's Arch Pharmacol

Self Cite

View full text Add to dashboard Cite

co-founder of the Archives, is generally recognized as the pioneer of experimental pharmacology and was the first to introduce the concept of pharmacodynamics and pharmacokinetics of a drug (Koch-Weser and Schechter 1978;Muscholl 1995;Starke 1998). Schmiedeberg received his education in pharmacology in Dorpart (Tartu) under the leadership of Rudolf Buchheim, the founder of pharmacology. The origins of the field of pharmacology are traced in a review article published in this issue (Philippu and Seifert 2023a). Another review in this issue analyzes the biographies of Schmiedeberg and several of his very successful students, the "Schmiedeberg school of pharmacology" (Philippu and Seifert, 2023b).In his 46 years at the University of Strassburg (Strasbourg in French), 120 pupils and students from 20 different countries of the world came to study under his guidance. Schmiedeberg trained many students so successfully that they later became professors at other German universities and in several foreign countries including the UK, the USA,

show abstract

Naunyn-Schmiedeberg’s Archives of Pharmacology under new editorship: change and continuity

Cited by 2 publications

References 46 publications

Bibliometric development of Naunyn–Schmiedeberg’s Archives of Pharmacology

Bibliometric development of Naunyn–Schmiedeberg’s Archives of Pharmacology

Reflections on the 150th anniversary of Naunyn–Schmiedeberg’s Archives of Pharmacology: past, challenges, and future

Contact Info

Product

Resources

About